ALEMBIC-BOSENTAN TABLET

国家: 加拿大

语言: 英文

来源: Health Canada

有效成分:

BOSENTAN (BOSENTAN MONOHYDRATE)

可用日期:

ALEMBIC PHARMACEUTICALS LIMITED

ATC代码:

C02KX01

INN（国际名称）:

BOSENTAN

剂量:

125MG

药物剂型:

TABLET

组成:

BOSENTAN (BOSENTAN MONOHYDRATE) 125MG

给药途径:

ORAL

每包单位数:

10/30/60/1000

处方类型:

Prescription

治疗领域:

VASODILATING AGENTS

產品總結:

Active ingredient group (AIG) number: 0145922002; AHFS:

授权状态:

APPROVED

授权日期:

2021-12-16

产品特点

______________________________________________________________________________
Alembic-Bosentan Page 1 of 42
PRODUCT MONOGRAPH
PR
ALEMBIC-BOSENTAN
Bosentan Tablets
62.5 mg and 125 mg Bosentan (as Bosentan Monohydrate)
Endothelin Receptor Antagonist
DATE OF REVISION:
December 13, 2021
MANUFACTURED BY:
Alembic Pharmaceuticals Limited
Alembic Road
Vadodara
–
390003
Gujarat, India
CANADIAN IMPORTER AND DISTRIBUTOR:
Alembic Pharmaceuticals Canada Ltd.
225
Gibraltar Road, Unit 5
Vaughn, Ontario
L4H 4P9
Control #
258718
______________________________________________________________________________
Alembic-Bosentan Page 2 of 42
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
......................................................... 3
SUMMARY PRODUCT INFORMATION
...........................................................................
3
INDICATIONS AND CLINICAL USE
..............................................................................
3
CONTRAINDICATIONS
...................................................................................................
3
WARNINGS AND PRECAUTIONS
.................................................................................
4
ADVERSE REACTIONS
...................................................................................................
8
DRUG INTERACTIONS
..................................................................................................
17
DOSAGE AND ADMINISTRATION
..............................................................................
20
OVERDOSAGE
................................................................................................................
21
ACTION AND CLINICAL PHARMACOLOGY
............................................................ 22
STORAGE AND
STABILITY..........................................................................................
24
SPECIAL HANDLING INSTRUCTIONS
.......................................................................
24
DOSAGE FORMS, COMPOSITION AND PACKAGING
.......................